Karine Grigoryan,Camelia Demetrescu,Ioannis Kasouridis et al.
Karine Grigoryan et al.
Structural valvular interventions have skyrocketed in the past decade with new devices becoming available and indications for patients who would previously have been deemed inoperable. Furthermore, while echocardiography is the main imaging...
Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation [0.03%]
射血分数保留的心力衰竭和房颤的治疗困境
Otilia Ţica,Waseem Khamboo,Dipak Kotecha
Otilia Ţica
Heart failure with preserved ejection fraction (HFpEF) and AF are two common cardiovascular conditions that are inextricably linked to each other's development and progression, often in multimorbid patients. Current management is often dire...
Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Outcomes in Left Ventricular Assist Device Patients with Aortic Insufficiency [0.03%]
左心室辅助装置患者主动脉瓣反流经导管主动脉瓣置换与外科主动脉瓣置换的结局比较
Aniket S Rali,Siva S Taduru,Lena E Tran et al.
Aniket S Rali et al.
Background: Worsening aortic insufficiency (AI) is a known sequela of prolonged continuous-flow left ventricular assist device (LVAD) support with a significant impact on patient outcomes. While medical treatment may relieve symptoms, it is...
Imaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges [0.03%]
女性心力衰竭患者影像学特征的性别差异及目前挑战
Isabella Leo,Eleni Nakou,Antonio de Marvao et al.
Isabella Leo et al.
Cardiovascular disease (CVD) represents a significant threat to women's health. Heart failure (HF) is one CVD that still has an increasing incidence and about half of all cases involve women. HF is characterised by strong sex-specific featu...
Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation? [0.03%]
为什么接受心力衰竭治疗的人中很少有人进行心脏康复？
David R Thompson,Chantal F Ski,Alexander M Clark et al.
David R Thompson et al.
Many people with heart failure do not receive cardiac rehabilitation despite a strong evidence base attesting to its effectiveness, and national and international guideline recommendations. A more holistic approach to heart failure rehabili...
Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction [0.03%]
射血分数保留的心力衰竭的流行病学及临床特点
Kanako Teramoto,Tiew-Hwa Katherine Teng,Chanchal Chandramouli et al.
Kanako Teramoto et al.
Heart failure (HF) with preserved ejection (HFpEF) constitutes a large and growing proportion of patients with HF around the world, and is now responsible for more than half of all HF cases in ageing societies. While classically described a...
Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients [0.03%]
不公正的心力衰竭治疗——黑人、西班牙裔和美洲原住民患者被忽视
Onyedika Ilonze,Kendall Free,Khadijah Breathett
Onyedika Ilonze
Despite the high prevalence of heart failure among Black and Hispanic populations, patients of colour are frequently under-prescribed guideline-directed medical therapy (GDMT) and American-Indian populations are not well characterised. Clin...
Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy [0.03%]
心力衰竭合并射血分数保留患者中钠-葡萄糖共转运体2抑制剂治疗的合理性及成功经验的实际运用
Mauro Gori,Emilia D&#x;Elia,Edoardo Sciatti et al.
Mauro Gori et al.
Heart failure (HF) with preserved left ventricular ejection fraction is a common disease with a poor prognosis and rising prevalence in the community. The current paradigm of treatment includes symptomatic therapy, such as diuretics, and ri...
Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis [0.03%]
射血分数保留的心力衰竭患者中心微血管功能障碍的病理生理学、评估、流行病学和预后
Joanna M Bilak,Uazman Alam,Christopher A Miller et al.
Joanna M Bilak et al.
Heart failure with preserved ejection fraction (HFpEF) currently accounts for approximately half of all new heart failure cases in the community. HFpEF is closely associated with chronic lifestyle-related diseases, such as obesity and type ...
Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect? [0.03%]
列钠-葡萄糖同向转运蛋白2抑制剂治疗射血分数保留的心力衰竭的临床证据及作用机制探讨：一种新的药物效应？
Brent Deschaine,Sahil Verma,Hussein Rayatzadeh
Brent Deschaine
Effective treatment for heart failure with preserved ejection fraction (HFpEF) is an unmet need in cardiovascular medicine. The pathophysiological drivers of HFpEF are complex, differing depending on phenotype, making a one-size-fits-all tr...